| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
DESN Stock Overview
Dottikon Es Holding AG engages in the manufacture and sale of performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide.
Dottikon Es Holding Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF218.00 |
| 52 Week High | CHF370.00 |
| 52 Week Low | CHF190.00 |
| Beta | 0.94 |
| 1 Month Change | -20.00% |
| 3 Month Change | -16.15% |
| 1 Year Change | -12.80% |
| 3 Year Change | 303.70% |
| 5 Year Change | 145.50% |
| Change since IPO | 976.54% |
Recent News & Updates
Why Dottikon Es Holding AG (VTX:DESN) Could Be Worth Watching
Dottikon Es Holding AG ( VTX:DESN ), is not the largest company out there, but it saw significant share price movement...
The Returns At Dottikon Es Holding (VTX:DESN) Aren't Growing
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
Shareholder Returns
| DESN | CH Chemicals | CH Market | |
|---|---|---|---|
| 7D | 0.5% | 5.7% | 3.8% |
| 1Y | -12.8% | -22.9% | -11.8% |
Return vs Industry: DESN exceeded the Swiss Chemicals industry which returned -22.9% over the past year.
Return vs Market: DESN underperformed the Swiss Market which returned -11.8% over the past year.
Price Volatility
| DESN volatility | |
|---|---|
| DESN Average Weekly Movement | 6.4% |
| Chemicals Industry Average Movement | 5.2% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in CH Market | 7.6% |
| 10% least volatile stocks in CH Market | 2.4% |
Stable Share Price: DESN is more volatile than 75% of Swiss stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: DESN's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1913 | 665 | Markus Blocher | https://dottikon.com |
Dottikon Es Holding AG engages in the manufacture and sale of performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also provides Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries.
Dottikon Es Holding Fundamentals Summary
| DESN fundamental statistics | |
|---|---|
| Market Cap | CHF3.00b |
| Earnings (TTM) | CHF59.29m |
| Revenue (TTM) | CHF251.93m |
50.7x
P/E Ratio11.9x
P/S RatioIs DESN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DESN income statement (TTM) | |
|---|---|
| Revenue | CHF251.93m |
| Cost of Revenue | CHF66.68m |
| Gross Profit | CHF185.26m |
| Other Expenses | CHF125.97m |
| Earnings | CHF59.29m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Nov 29, 2022
| Earnings per share (EPS) | 4.30 |
| Gross Margin | 73.53% |
| Net Profit Margin | 23.53% |
| Debt/Equity Ratio | 0.0% |
How did DESN perform over the long term?
See historical performance and comparisonValuation
Is DESN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DESN?
Other financial metrics that can be useful for relative valuation.
| What is DESN's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | CHF3.00b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 11.1x |
| Enterprise Value/EBITDA | 30.4x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does DESN's PE Ratio compare to its peers?
| DESN PE Ratio vs Peers |
|---|
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 32.1x | ||
CLN Clariant | 22.2x | 13.2% | CHF5.9b |
EMSN EMS-CHEMIE HOLDING | 30.4x | 8.7% | CHF16.7b |
GURN Gurit Holding | 38.7x | 32.7% | CHF439.6m |
GIVN Givaudan | 37.3x | 9.0% | CHF30.6b |
DESN Dottikon Es Holding | 50.7x | n/a | CHF3.0b |
Price-To-Earnings vs Peers: DESN is expensive based on its Price-To-Earnings Ratio (50.7x) compared to the peer average (32.1x).
Price to Earnings Ratio vs Industry
How does DESN's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Earnings vs Industry: DESN is expensive based on its Price-To-Earnings Ratio (50.7x) compared to the Swiss Chemicals industry average (35.1x)
Price to Earnings Ratio vs Fair Ratio
What is DESN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 50.7x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DESN's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of DESN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate DESN's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate DESN's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DESN's PEG Ratio to determine if it is good value.
Discover undervalued companies
Future Growth
How is Dottikon Es Holding forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
11.5%
Forecasted Materials industry annual growth in earnings
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if DESN's forecast earnings growth is above the savings rate (-0.3%).
Earnings vs Market: Insufficient data to determine if DESN's earnings are forecast to grow faster than the Swiss market
High Growth Earnings: Insufficient data to determine if DESN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if DESN's revenue is forecast to grow faster than the Swiss market.
High Growth Revenue: Insufficient data to determine if DESN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DESN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Past Performance
How has Dottikon Es Holding performed over the past 5 years?
Past Performance Score
1/6Past Performance Score 1/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
25.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DESN has a high level of non-cash earnings.
Growing Profit Margin: DESN's current net profit margins (23.5%) are lower than last year (23.9%).
Past Earnings Growth Analysis
Earnings Trend: DESN's earnings have grown significantly by 25% per year over the past 5 years.
Accelerating Growth: DESN's earnings growth over the past year (13.3%) is below its 5-year average (25% per year).
Earnings vs Industry: DESN earnings growth over the past year (13.3%) underperformed the Chemicals industry 20%.
Return on Equity
High ROE: DESN's Return on Equity (8.3%) is considered low.
Discover strong past performing companies
Financial Health
How is Dottikon Es Holding's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: DESN's short term assets (CHF426.4M) exceed its short term liabilities (CHF106.3M).
Long Term Liabilities: DESN's short term assets (CHF426.4M) exceed its long term liabilities (CHF37.1M).
Debt to Equity History and Analysis
Debt Level: DESN is debt free.
Reducing Debt: DESN has not had any debt for past 5 years.
Debt Coverage: DESN has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: DESN has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Dividend
What is Dottikon Es Holding current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DESN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DESN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DESN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DESN's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: DESN is not paying a notable dividend for the Swiss market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as DESN has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
10.8yrs
Average management tenure
CEO
Markus Blocher (50 yo)
19.42yrs
Tenure
CHF580,000
Compensation
Dr. Markus Blocher, Dipl. Chem. ETH, Dr. sc. nat. ETH, PhD has been the Chief Executive Officer of Dottikon Es Holding Ag since 2003 and serves as its Chairman of the Board and Managing Director. Dr. Bloc...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Markus's total compensation is reasonable compared to companies of similar size in the Swiss market.
Compensation vs Earnings: Markus's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: DESN's management team is seasoned and experienced (10.8 years average tenure).
Board Members
Experienced Board: DESN's board of directors are seasoned and experienced ( 10.9 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Dottikon Es Holding AG's employee growth, exchange listings and data sources
Key Information
- Name: Dottikon Es Holding AG
- Ticker: DESN
- Exchange: SWX
- Founded: 1913
- Industry: Specialty Chemicals
- Sector: Materials
- Implied Market Cap: CHF3.005b
- Shares outstanding: 13.78m
- Website: https://dottikon.com
Number of Employees
Location
- Dottikon Es Holding AG
- Hembrunnstrasse 17
- Dottikon
- Aargau
- 5605
- Switzerland
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/28 00:00 |
| End of Day Share Price | 2022/06/28 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2022/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.